Xcout Intel
Travere Therapeutics, Inc.
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Subscribe to see Travere Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Travere Therapeutics, Inc. at a glance
Travere Therapeutics, Inc. is a biotechnology company headquartered in San Diego, United States, founded in 2008. It is publicly listed (TVTX) with a market capitalisation of $4.8B. Xcout tracks 32 named people at Travere Therapeutics, Inc., including Eric Dube (President, Chief Executive Officer & Director). Xcout recorded 90 job postings from Travere Therapeutics, Inc. in the last 90 days, naming tools such as ChatGPT, Salesforce.
Travere Therapeutics, Inc. leadership
- Eric DubePresident, Chief Executive Officer & Director
- Eric Dube, Ph.D.President & Chief Executive Officer
- Christopher ClineChief Financial Officer
- Chris Cline, CFAChief Financial Officer
- Jula InrigExecutive VP, Head of Research & Development and Chief Medical Officer
- Peter HeermaChief Commercial Officer
26 more named people on record for Travere Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Travere Therapeutics, Inc.
Xcout recorded 90 job postings from Travere Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Travere Therapeutics, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Travere Therapeutics, Inc.'s hiring signals →
Recent Travere Therapeutics, Inc. news
- Leadership changeTravere Therapeutics appoints new CEO Bradley Campbell
3 corporate events on record, with sources — see the full timeline →
Hiring vs the trend
Based on 44 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 168 enterprise healthcare companies.
This describes a hiring pattern — how often Travere Therapeutics, Inc.’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Travere Therapeutics, Inc. competitors
A few of Travere Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
Amicus Therapeutics, a subsidiary of BioMarin Pharmaceutical Inc., is a biotechnology company that researches and delivers medicines for individuals living with genetically defined rare diseases. The company provides patient advocacy and support services alongside its clinical development pipeline.
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company located in San Diego, California. The company is committed to developing cutting-edge RNA-targeted therapeutics to treat various genetic and severe diseases. ADARx focuses on translating scientific research into life-saving medicines through its proprietary drug discovery pipeline.
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Amicus Therapeutics, Inc. is an American biopharmaceutical company focused on discovering and delivering advanced therapies for rare diseases. The company is publicly traded on Nasdaq and maintains its global corporate headquarters in Princeton, New Jersey.
Applied Therapeutics, Inc. is a biopharmaceutical company headquartered in New York City, focused on developing novel product candidates targeted at disease targets involving enzyme and metabolic pathways.
Get Travere Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Travere Therapeutics, Inc. in Xcout Intel
- 32 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access